Xiaoying Wei

502 total citations
26 papers, 353 citations indexed

About

Xiaoying Wei is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Xiaoying Wei has authored 26 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Xiaoying Wei's work include Cancer Immunotherapy and Biomarkers (6 papers), Esophageal Cancer Research and Treatment (6 papers) and Esophageal and GI Pathology (3 papers). Xiaoying Wei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Esophageal Cancer Research and Treatment (6 papers) and Esophageal and GI Pathology (3 papers). Xiaoying Wei collaborates with scholars based in China, United States and Nepal. Xiaoying Wei's co-authors include Weihua Zhang, X. Hao, Ruifang Niu, Yu Shi, Yiling Yang, Qingsong Pang, Zhiyong Yuan, Ping Wang, Jingjing Cheng and Ximei Zhang and has published in prestigious journals such as Chemical Communications, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.

In The Last Decade

Xiaoying Wei

24 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoying Wei China 9 144 125 66 59 55 26 353
Jarosław Szefel Poland 12 123 0.9× 133 1.1× 65 1.0× 83 1.4× 37 0.7× 25 374
Zhenzhong Feng China 11 152 1.1× 130 1.0× 59 0.9× 85 1.4× 70 1.3× 29 371
Siddharth Mehra United States 13 209 1.5× 255 2.0× 95 1.4× 38 0.6× 38 0.7× 20 468
Qiaonan Shan China 12 305 2.1× 173 1.4× 101 1.5× 63 1.1× 73 1.3× 16 547
Julie Talbot France 8 172 1.2× 86 0.7× 84 1.3× 74 1.3× 28 0.5× 10 378
Xiuling Li China 14 228 1.6× 108 0.9× 145 2.2× 82 1.4× 26 0.5× 29 468
Syed F. Zafar United States 9 132 0.9× 111 0.9× 65 1.0× 51 0.9× 48 0.9× 18 355

Countries citing papers authored by Xiaoying Wei

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Wei more than expected).

Fields of papers citing papers by Xiaoying Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Wei. The network helps show where Xiaoying Wei may publish in the future.

Co-authorship network of co-authors of Xiaoying Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Wei. A scholar is included among the top collaborators of Xiaoying Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Wei. Xiaoying Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Meng, Jian Qiao, Wenjing Wei, et al.. (2025). Doxorubicin carrier based on an HCOF platform for potent cancer therapy. Dalton Transactions. 54(24). 9749–9753. 1 indexed citations
2.
3.
Wei, Xiaoying, Huiquan Liu, Jianguo Wang, et al.. (2025). Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway. Journal for ImmunoTherapy of Cancer. 13(1). e009993–e009993. 6 indexed citations
4.
Liu, Rui, Wenhua Lu, Jing Yang, et al.. (2025). SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer. Cancer Letters. 616. 217586–217586. 3 indexed citations
5.
Liang, Shan, Shiwei Liu, Zhihe Long, et al.. (2025). A self-powered hydration-monitoring and drug-delivery skin patch for closed-loop treatment of atopic dermatitis. Microsystems & Nanoengineering. 11(1). 156–156. 1 indexed citations
6.
Zhang, Ke, Songwei Feng, Qi Liu, et al.. (2025). Development of model for identifying homologous recombination deficiency (HRD) status of ovarian cancer with deep learning on whole slide images. Journal of Translational Medicine. 23(1). 267–267. 1 indexed citations
7.
Wang, Yan, Wenjing Wei, Xiaoying Wei, et al.. (2025). Construction of a hydrogen-bonded organic framework-based therapeutic platform by one-pot method. Chemical Communications. 61(17). 3560–3563. 3 indexed citations
10.
Ren, Lihua, Rong Chen, Qin Lu, et al.. (2022). Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma. World Journal of Gastrointestinal Oncology. 14(9). 1758–1770. 3 indexed citations
11.
Ma, Xiaoxue, Xiaoying Wei, Gang Zhao, et al.. (2022). Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade. Frontiers in Immunology. 12. 786429–786429. 28 indexed citations
12.
Li, Yang, Xiaoying Wei, Yanqi Li, et al.. (2021). A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis. Frontiers in Oncology. 11. 703074–703074. 2 indexed citations
13.
Wang, Juntao, Peng Jiao, Xiaoying Wei, & Yun Zhou. (2021). Silencing Long Non-coding RNA Kcnq1ot1 Limits Acute Kidney Injury by Promoting miR-204-5p and Blocking the Activation of NLRP3 Inflammasome. Frontiers in Physiology. 12. 721524–721524. 9 indexed citations
14.
Wei, Xiaoying, et al.. (2020). Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells. Frontiers in Bioengineering and Biotechnology. 8. 598997–598997. 61 indexed citations
15.
Dong, Jie, Wencheng Zhang, Tian Zhang, et al.. (2020). Baseline nutritional status could be a predictor for radiation esophagitis in esophageal cancer patients undergoing radiotherapy. Annals of Translational Medicine. 8(18). 1148–1148. 18 indexed citations
16.
Wei, Xiaoying, et al.. (2020). T lymphocytes related biomarkers for predicting immunotherapy efficacy in non‑small cell lung cancer (Review). Oncology Letters. 21(2). 89–89. 7 indexed citations
17.
Zhang, Chen‐Yu, et al.. (2016). [A case-control study on the association between serum lipid level and the risk of breast cancer].. PubMed. 50(12). 1091–1095. 20 indexed citations
18.
Lee, Jong‐Dae, Guy Hughes, Yuhong Chen, et al.. (2013). Association of LIPC and advanced age-related macular degeneration. Eye. 27(2). 265–271. 17 indexed citations
19.
Niu, Ruifang, et al.. (2007). Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma.. PubMed. 26(3). 385–94. 93 indexed citations
20.
Wei, Xiaoying, et al.. (1987). 5-fluorouracil (5-Fu) in the treatment of prostatic hyperplasia. Urological Research. 15(1). 35–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026